Insider: Matsuda Masaru See Remarks - Arcutis Biotherapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 161,234 | 0 | 161,234 |
| Value | $2,829,656.70 | $0.00 | $2,829,656.70 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/04/2025 | DDS | 36,130 | Direct | COM | $16.16 | $583,716.28 | 161,234 |
| 08/04/2025 | DDS | 6,330 | Direct | COM | $14.33 | $90,687.38 | 197,364 |
| 05/28/2025 | DDS | 1,800 | Direct | COM | $13.78 | $24,806.52 | 202,599 |
| 05/02/2025 | DDS | 5,030 | Direct | COM | $15.20 | $76,453.49 | 204,399 |
| 03/03/2025 | DDS | 3,263 | Direct | COM | $13.03 | $42,520.48 | 209,429 |
| 02/03/2025 | DDS | 8,338 | Direct | COM | $12.70 | $105,892.60 | 178,692 |
| 11/30/2024 | AAP | 1,657 | Direct | COM | $7.11 | $11,774.64 | 187,030 |
| 11/19/2024 | DDS | 1,775 | Direct | COM | $9.68 | $17,190.34 | 181,373 |
| 11/04/2024 | DDS | 5,015 | Direct | COM | $8.68 | $43,551.26 | 178,273 |
| 08/02/2024 | DDS | 5,220 | Direct | COM | $9.02 | $47,064.04 | 183,288 |
| 05/31/2024 | AAP | 4,000 | Direct | COM | $1.69 | $6,768.00 | 185,373 |
| 05/28/2024 | DDS | 1,775 | Direct | COM | $9.01 | $15,988.14 | 188,508 |
| 05/02/2024 | DDS | 5,016 | Direct | COM | $8.74 | $43,828.80 | 185,408 |
| 03/04/2024 | DDS | 3,760 | Direct | COM | $11.12 | $41,815.71 | 190,424 |
| 11/21/2023 | DDS | 1,850 | Direct | COM | $1.98 | $3,661.15 | 46,634 |
| 05/31/2023 | DDS | 1,830 | Direct | COM | $7.80 | $14,278.21 | 42,146 |
| 03/02/2023 | DDS | 1,416 | Direct | COM | $15.82 | $22,398.43 | 18,119 |
| 03/02/2023 | DDS | 18 | Direct | COM | $16.52 | $297.36 | 18,101 |
| 11/21/2022 | DDS | 1,720 | Direct | COM | $18.19 | $31,288.86 | 19,535 |
| 06/02/2022 | DDS | 1,795 | Direct | COM | $19.73 | $35,418.58 | 16,380 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research